anticancer potential of clk kinase inhibitors 1c8 and gps167 | oncotarget
Published 6 months ago • 49 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
4:20
tyrosine kinase inhibitors (tkis) - imatinib (gleevec) - pharmacology - cml and all
-
14:36
hematology in 10 min: hypercoagulobility state and application
-
3:12
hcc whiteboard #3: the management of adverse events of tyrosine kinase inhibitors
-
14:46
targeting protein tyrosine kinase receptor, csf1r, in chicken primordial germ cells using crisprs
-
3:30
innovative uses of kinase inhibitors in cancer
-
37:38
human protein kinase ck2 inhibitors: discovering new scaffolds
-
3:42
cyclin-dependent kinase 4 (cdk4) inhibition and metastatic breast cancer
-
25:12
il-12/23 inhibitors and small molecule inhibitors
-
4:22
selective kinase inhibitors of the tyk2 protein, tyra jones
-
1:06
dr. smith on pi3k inhibitors in cll
-
7:38
factors to consider in choosing alk tkis in frontline setting
-
55:39
p-21 activated kinases as therapeutic targets in breast cancer
-
1:47
development of autophagy inhibitors to treat ovarian cancer - dr alan richardson, keele university
-
6:45
anti-pd1 or tyrosine kinase inhibitors?
-
9:40
how does the protein kinase akt enable tumours to grow?
-
2:13
is glioma cell invasion dependent on the dna damage response kinase atr?
-
32:40
a tyrosine kinase protein interaction map reveals targetable egfr network oncogenesis in lung cancer
-
30:55
targeting the phosphoinositide-3 kinase (pi3k) pathway in breast cancer - josé baselga, md
-
2:08
for physicians: vegf tyrosine kinase inhibitor treatment risks | dana-farber cancer institute